Tokyo

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis1 trial
• Cystic fibrosis1 trial
• Fabry disease1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Sanofi3 trials

Running trials

• Active, not recruiting

  Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

  NCT06791291· Phase 2· Sanofi· Source

• Active, not recruiting

  A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease

  NCT05206773· Phase 3· Sanofi· Source

Closed trials

• Completed

  A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· Phase 2· Sanofi· Source